UBS Group Lowers Blend Labs (NYSE:BLND) Price Target to $2.00

Blend Labs (NYSE:BLND) had its target price decreased by equities researchers at UBS Group from $3.00 to $2.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price objective would indicate a potential upside of 10.80% from the company’s current price.

Other equities research analysts have also issued research reports about the stock. Wells Fargo & Company dropped their price objective on shares of Blend Labs from $5.00 to $4.00 and set an “overweight” rating on the stock in a research note on Wednesday. Wall Street Zen upgraded Blend Labs from a “sell” rating to a “hold” rating in a research note on Sunday, November 16th. Citizens Jmp dropped their price target on Blend Labs from $7.00 to $5.00 and set a “market outperform” rating on the stock in a research report on Wednesday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Blend Labs in a report on Wednesday, January 21st. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Blend Labs presently has an average rating of “Hold” and a consensus price target of $4.13.

Blend Labs Trading Up 10.7%

Blend Labs stock traded up $0.18 during mid-day trading on Wednesday, reaching $1.81. The company’s stock had a trading volume of 10,718,896 shares, compared to its average volume of 3,427,091. Blend Labs has a twelve month low of $1.57 and a twelve month high of $4.49. The business has a 50 day moving average price of $2.33 and a 200-day moving average price of $3.02. The firm has a market cap of $468.85 million, a price-to-earnings ratio of -18.05 and a beta of 1.27.

Blend Labs (NYSE:BLND) last issued its earnings results on Tuesday, March 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.04). The business had revenue of $32.37 million for the quarter, compared to the consensus estimate of $31.78 million. On average, equities analysts expect that Blend Labs will post -0.19 EPS for the current fiscal year.

Insider Transactions at Blend Labs

In other Blend Labs news, insider Brian Kneafsey sold 25,000 shares of the business’s stock in a transaction dated Thursday, January 15th. The shares were sold at an average price of $3.06, for a total transaction of $76,500.00. Following the completion of the transaction, the insider directly owned 649,824 shares of the company’s stock, valued at $1,988,461.44. The trade was a 3.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last ninety days, insiders have sold 33,125 shares of company stock worth $93,169. Insiders own 35.52% of the company’s stock.

Institutional Investors Weigh In On Blend Labs

A number of hedge funds have recently made changes to their positions in the business. Caitong International Asset Management Co. Ltd acquired a new position in shares of Blend Labs during the third quarter worth approximately $32,000. Captrust Financial Advisors acquired a new stake in Blend Labs in the 2nd quarter valued at approximately $35,000. South Shore Capital Advisors bought a new stake in Blend Labs during the 4th quarter valued at $36,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Blend Labs during the 2nd quarter worth $37,000. Finally, Savvy Advisors Inc. bought a new position in shares of Blend Labs in the third quarter worth $37,000. Institutional investors own 52.56% of the company’s stock.

Key Stories Impacting Blend Labs

Here are the key news stories impacting Blend Labs this week:

• Positive Sentiment: Company announced a $50 million share buyback, supporting near‑term demand for shares and helping lift the stock. MSN: Buyback & Stock Reaction
• Positive Sentiment: CEO Nima Ghamsari expressed strong conviction in the business (“I have never been more excited”), which can bolster investor confidence despite short‑term weakness. 247WallSt: CEO Comments
• Positive Sentiment: Revenue slightly beat expectations ($32.37M vs. $31.78M), showing ongoing top‑line momentum that investors often reward even when profitability lags. MarketBeat: Q4 Results
• Neutral Sentiment: Company released the earnings press release, slide deck and call transcript — useful for investors wanting detail but not market‑moving by itself. Press Release / Slide Deck
• Negative Sentiment: Reported EPS missed: ($0.03) vs. $0.01 expected, a clear negative on near‑term profitability that pressured sentiment. MarketBeat: EPS Miss
• Negative Sentiment: Q1 revenue guidance was cut to $28.5M–$30.0M vs. consensus ~$31.9M, highlighting near‑term headwinds and prompting analyst model revisions. Yahoo Finance: Preliminary Q1 Guidance
• Negative Sentiment: Several analysts trimmed forecasts and price targets after the print (e.g., Wells Fargo cut target $5→$4 but remains overweight; Citizens Jmp cut $7→$5 but kept an outperform stance), adding downward pressure on sentiment. Benzinga: Analyst Cuts TickerReport: Citizens Jmp Note

About Blend Labs

Blend Labs, Inc operates as a financial technology company that offers a digital consumer banking platform designed to simplify and automate the lending and account opening processes for banks and credit unions. Its cloud-native software enables financial institutions to deliver a more seamless customer experience by consolidating multiple steps—such as application intake, identity verification, document collection and underwriting—into a unified digital workflow. Blend’s platform is built to integrate with existing core banking systems and third-party data providers, allowing clients to accelerate loan origination and deposit account opening while maintaining compliance and security standards.

The company’s product suite includes solutions for mortgage origination, home equity lending, consumer personal lending and deposit account opening.